This Article  • Full text  • PDF  • JAMA News Video  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (29)  • Contact me when this article is cited  Related Content  • Related letter  • Similar articles in JAMA  Topic Collections  • Randomized Controlled Trial  • Diet  • Hypertension  • Alert me on articles by topic  Social Bookmarking   What's this?

A Randomized Controlled Trial

Dirk Taubert, MD, PhD; Renate Roesen, PhD; Clara Lehmann, MD; Norma Jung, MD; Edgar Schömig, MD

JAMA. 2007;298:49-60.

Context  Regular intake of cocoa-containing foods is linked to lower cardiovascular mortality in observational studies. Short-term interventions of at most 2 weeks indicate that high doses of cocoa can improve endothelial function and reduce blood pressure (BP) due to the action of the cocoa polyphenols, but the clinical effect of low habitual cocoa intake on BP and the underlying BP-lowering mechanisms are unclear.

Objective  To determine effects of low doses of polyphenol-rich dark chocolate on BP.

Design, Setting, and Participants  Randomized, controlled, investigator-blinded, parallel-group trial involving 44 adults aged 56 through 73 years (24 women, 20 men) with untreated upper-range prehypertension or stage 1 hypertension without concomitant risk factors. The trial was conducted at a primary care clinic in Germany between January 2005 and December 2006.

Intervention  Participants were randomly assigned to receive for 18 weeks either 6.3 g (30 kcal) per day of dark chocolate containing 30 mg of polyphenols or matching polyphenol-free white chocolate.

Main Outcome Measures  Primary outcome measure was the change in BP after 18 weeks. Secondary outcome measures were changes in plasma markers of vasodilative nitric oxide (S-nitrosoglutathione) and oxidative stress (8-isoprostane), and bioavailability of cocoa polyphenols.

Results  From baseline to 18 weeks, dark chocolate intake reduced mean (SD) systolic BP by –2.9 (1.6) mm Hg (P < .001) and diastolic BP by –1.9 (1.0) mm Hg (P < .001) without changes in body weight, plasma levels of lipids, glucose, and 8-isoprostane. Hypertension prevalence declined from 86% to 68%. The BP decrease was accompanied by a sustained increase of S-nitrosoglutathione by 0.23 (0.12) nmol/L (P < .001), and a dark chocolate dose resulted in the appearance of cocoa phenols in plasma. White chocolate intake caused no changes in BP or plasma biomarkers.

Conclusions  Data in this relatively small sample of otherwise healthy individuals with above-optimal BP indicate that inclusion of small amounts of polyphenol-rich dark chocolate as part of a usual diet efficiently reduced BP and improved formation of vasodilative nitric oxide.

Trial Registration  clinicaltrials.gov Identifier: NCT00421499

Author Affiliations: Departments of Pharmacology (Drs Taubert, Roesen, and Schömig) and Internal Medicine (Drs Lehmann and Jung), University Hospital of Cologne, Cologne, Germany.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED LETTER

Cocoa Intake and Blood Pressure
Dimitrios Tsikas and Ranieri Rossi
JAMA. 2007;298(16):1862-1863.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Fish, Vitamin D, and Flavonoids in Relation to Renal Cell Cancer Among Smokers
Wilson et al.
Am J Epidemiol 2009;170:717-729.
ABSTRACT | FULL TEXT  

Milk decreases urinary excretion but not plasma pharmacokinetics of cocoa flavan-3-ol metabolites in humans
Mullen et al.
Am. J. Clin. Nutr. 2009;89:1784-1791.
ABSTRACT | FULL TEXT  

Cocoa and Cardiovascular Health
Corti et al.
Circulation 2009;119:1433-1441.
ABSTRACT | FULL TEXT  

Cocoa consumption for 2 wk enhances insulin-mediated vasodilatation without improving blood pressure or insulin resistance in essential hypertension
Muniyappa et al.
Am. J. Clin. Nutr. 2008;88:1685-1696.
ABSTRACT | FULL TEXT  

Reduction of C-reactive protein with isoflavone supplement reverses endothelial dysfunction in patients with ischaemic stroke
Chan et al.
Eur Heart J 2008;29:2800-2807.
ABSTRACT | FULL TEXT  

Complementary and alternative medicine approaches to blood pressure reduction: An evidence-based review
Nahas
cfp 2008;54:1529-1533.
ABSTRACT | FULL TEXT  

Regular Consumption of Dark Chocolate Is Associated with Low Serum Concentrations of C-Reactive Protein in a Healthy Italian Population
di Giuseppe et al.
J. Nutr. 2008;138:1939-1945.
ABSTRACT | FULL TEXT  

Blood Pressure Is Reduced and Insulin Sensitivity Increased in Glucose-Intolerant, Hypertensive Subjects after 15 Days of Consuming High-Polyphenol Dark Chocolate
Grassi et al.
J. Nutr. 2008;138:1671-1676.
ABSTRACT | FULL TEXT  

Tea, Flavonoids, and Nitric Oxide-Mediated Vascular Reactivity
Grassi et al.
J. Nutr. 2008;138:1554S-1560S.
ABSTRACT | FULL TEXT  

Acute dark chocolate and cocoa ingestion and endothelial function: a randomized controlled crossover trial
Faridi et al.
Am. J. Clin. Nutr. 2008;88:58-63.
ABSTRACT | FULL TEXT  

A new favourable effect of cocoa on atherosclerosis?
Paramo
Cardiovasc Res 2008;79:3-4.
FULL TEXT  

Sustained benefits in vascular function through flavanol-containing cocoa in medicated diabetic patients a double-masked, randomized, controlled trial.
Balzer et al.
J Am Coll Cardiol 2008;51:2141-2149.
ABSTRACT | FULL TEXT  

Daily Consumption of a Dark Chocolate Containing Flavanols and Added Sterol Esters Affects Cardiovascular Risk Factors in a Normotensive Population with Elevated Cholesterol
Allen et al.
J. Nutr. 2008;138:725-731.
ABSTRACT | FULL TEXT  

What's new in hypertension 2007?
Mann
Nephrol Dial Transplant 2008;23:466-470.
FULL TEXT  

Cocoa Intake and Blood Pressure
Tsikas and Rossi
JAMA 2007;298:1862-1863.
FULL TEXT  

Evidently...
Lehman
Evid. Based Med. 2007;12:135-135.
FULL TEXT  

Other articles noted
Evid. Based Med. 2007;12:159-160.
FULL TEXT  

Dark Chocolate for Your Blood Pressure?
JWatch Women's Health 2007;2007:1-1.
FULL TEXT  

Beneficial Effects of Cocoa
JWatch General 2007;2007:3-3.
FULL TEXT